CYSTETIC MEDICINES
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.
CYSTETIC MEDICINES
Industry:
Biotechnology Genetics Health Care
Founded:
2019-01-01
Status:
Active
Total Funding:
25 M USD
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Illinois Ventures
Illinois Ventures investment in Funding Round - Cystetic Medicines
Deerfield
Deerfield investment in Funding Round - Cystetic Medicines
More informations about "Cystetic Medicines"
Company - Cystetic Medicine
About cystetic Medicines One simple therapy for allof the final 10% cystetic Medicines exists to bring accessible treatment to every person with cystic fibrosis—especially those who have …See details»
Cystetic Medicines - Crunchbase Company Profile
Organization. Cystetic Medicines . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About. Cystetic …See details»
Cystetic Medicines | Deerfield
Cystetic Medicines is a Deerfield portfolio company.See details»
Cystetic Medicines - Funding, Financials, Valuation & Investors
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation. Search Crunchbase. ... How much funding has this …See details»
Cystetic Medicines - Contacts, Employees, Board Members
Organization. Cystetic Medicines . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Cystetic …See details»
Cystetic Medicines - PitchBook
Cystetic Medicines General Information Description. Developer of a cystic fibrosis drug designed to provide a new way to treat the disease. The company specializes in creating novel inhaled …See details»
Cystetic Medicines, Inc. - Drug pipelines, Patents, Clinical ... - Patsnap
The organization of these sections reflects the key pharmacological categories. ... cystetic Medicine to present CM001 Phase 1 Single Ascending Dose Data at North American Cystic …See details»
Cystetic Medicines Doses First Person with Cystic …
Jun 26, 2023 CHAMPAIGN, Ill., Oct. 30, 2023 /PRNewswire/ — cystetic Medicines, Inc., a clinical-stage biotechnology company developing small molecule channels that serve as molecular prosthetics for missing or …See details»
Company co-founded by Carle Illinois faculty
Dec 18, 2020 A research team led by Marty Burke, associate dean of research at Carle Illinois College of Medicine, in collaboration with Mike Welsh and his team at the University of Iowa, has developed a new treatment that potentially …See details»
Orphanet: cystetic Medicines, Inc.
Cystetic Medicines, Inc. cystetic Medicines, Inc. 1403 Old Farm Road. 61821 CHAMPAIGN . UNITED STATES. Phone 1: [email protected] Institution's website Contacts. …See details»
Cystetic Medicines begins Phase 1 trial of ‘molecular prosthetics’ …
Jul 1, 2023 Cystetic Medicines, a company that makes small-molecule channels to be used as molecular prosthetics for the cystic fibrosis transmembrane conductance regulator (CFTR) …See details»
Cystetic Medicines - Crunchbase
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation. Search Crunchbase. Start Free Trial . Chrome …See details»
Cystetic Medicines doses first person | C&EN Global Enterprise
Jul 3, 2023 Cystetic Medicines, a company that makes small-molecule channels to be used as molecular prosthetics for the cystic fibrosis transmembrane conductance regulator (CFTR) …See details»
cystetic Medicines Initiates Phase 1 Clinical Trial of a Molecular ...
Jun 26, 2023 Novel approach could treat the final 10% of people with CF that cannot benefit from CFTR modulators Data from Phase 1 study expected in Q4 of 2023 CHAMPAIGN, Ill., …See details»
Dosing to Begin in Phase 1 Trial of CF Experimental Drug CM001
Jun 26, 2023 The first healthy volunteer has been dosed with CM001, a molecular prosthetic for missing or dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein …See details»
cystetic Medicines Initiates Phase 1 Clinical Trial of a Molecular ...
Jun 26, 2023 cystetic Medicines was co-founded in 2020 by Burke, a chemist at the University of Illinois at Urbana-Champaign, and Michael Welsh, M.D., a physician-scientist at the University …See details»
Cystetic Medicines Doses First Person With Cystic Fibrosis in Phase …
CHAMPAIGN, Ill., Oct. 30, 2023 /PRNewswire/ -- cystetic Medicines, Inc., a clinical-stage biotechnology company developing small molecule channels that serve as molecular …See details»
Our Approach - Cystetic Medicine
Approach Simplicity. Accessibility. Breath. Stopgap measures like antibiotics, anti-inflammatory drugs, chest percussion, and osmotic agents can help mitigate symptoms of cystic fibrosis, …See details»
Cystetic Medicines - Updates, News, Events, Signals & Triggers
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation. Search Crunchbase. Start Free Trial . Chrome …See details»
Sotatercept in Patients with Pulmonary Arterial Hypertension at …
2 days ago Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial …See details»